reports
Moody's Ratings assigns Ba3 rating to Owens & Minor's new senior secur...
Moody's Ratings (Moody's) assigned a Ba3 rating to Owens & Minor, Inc.'s ("Owens & Minor") proposed $1 billion senior secured notes. There are no changes to Owens & Minor's existing ratings including the Ba3 Corporate Family Rating (CFR), Ba3-PD Probability of Default Rating (PDR), Ba3 senior secure...
Moody's Ratings affirms Owens & Minor's Ba3 CFR, assigns Ba3 to propos...
Moody's Ratings (Moody's) affirmed Owens & Minor, Inc.'s ("Owens & Minor") Ba3 corporate family rating (CFR), Ba3-PD probability of default rating (PDR), Ba3 ratings on its existing senior secured first lien bank credit facilities, and B2 ratings on the company's senior unsecured notes. Concurrently...
- Jonathan Moreland
InsiderInsights.com Daily Ratings Report: March 4, 2025
InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
VAC MARRIOTT VACATIONS WORLDWIDE CORPORATION
TDOC TELADOC HEALTH INC.
PBF PBF ENERGY INC. CLASS A
OMI OWENS & MINOR INC.
MTDR MATADOR RESOURCES COMPANY
LTRX LANTRONIX INC.
JCOM J2 GLOBAL INC.
FTAI FORTRESS TRANSPORTATION AND INFRASTRUCTURE INVESTORS LLC
FLDM FLUIDIGM
CDXS CODEXIS
FMC FMC CORPORATION
GTN GRAY TELEVISION INC.
PETS PETMED EXPRESS INC.
DMLP DORCHESTER MINERALS L.P.
LBSRD LIBERTY STAR URANIUM & METALS
GO GROCERY OUTLET HOLDING
PSN PARSONS
CAPR CAPRICOR THERAPEUTICS
VERX VERTEX
ORIC INC.
NOG ORIC PHARMACEUTICALS
PFBX NORTHERN OIL AND GAS
ALIT PEOPLES FINANCIAL CORP. (MISSISSIPPI)
TMCI ALIGHT
AVDX INC. / DELAWARE
FLYW TREACE MED CONCEPTS INC
MBC_w AVIDXCHANGE HLDGS INC
MRNA FLYWIRE CORP
CVI MASTERBRAND INC
GF MODERNA
INC.
CVR ENERGY
INC.
THE NEW GERMANY FUND
INC.
Owens & Minor Reports Fourth Quarter & Full Year Financial Results and...
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2024. “We are pleased with the progress that we have made against the strategy as outlined at our Investor Day in December 2023. As a reminder, we committed to optimizing our Products & Healthcare Services business, leveraging our leading Patient Direct platform, and building balance sheet flexibility through deleveraging. Within P&HS we continue to see momentum in broadening our product portfolio, developing a streamlined and efficient manufact...
Owens & Minor Launches Financing for Rotech Acquisition and Provides P...
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE: OMI) (the “Company”) today announced selected preliminary financial results for the fourth quarter and year ended December 31, 2024 in advance of its upcoming earnings announcement and conference call. The release of the preliminary results relates to the Company’s commencement of financing activity related to its previously announced agreement to acquire Rotech Healthcare Holdings, Inc (“Rotech”). “We are commencing a process to raise additional debt while the capital markets are attractive, to finance our previously announced agre...
Owens & Minor, Inc. - September 2024 (LTM): Peer Snapshot
Compares key performance metrics against industry peers.
Owens & Minor to Present at Upcoming Investor Conferences
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE: OMI), announced today that members of its management team are scheduled to participate in two upcoming investor conferences. Citi 2024 Global Healthcare Conference On Wednesday, December 4, 2024, Owens & Minor is scheduled to participate in a fireside chat at 8:45 a.m. ET and host individual investor meetings at the conference in Miami, Florida. Bank of America Home Care Conference On Monday, December 9, 2024, Owens & Minor is scheduled to participate in a fireside chat at 12:00 p.m. ET and host individual investor meetings at the...
Owens & Minor Reports Third Quarter 2024 Financial Results
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2024. Key Highlights: Consolidated revenue of $2.7 billion in the third quarter, representing year-over-year growth of 5% GAAP Net loss of $(13) million or $(0.17) per share, and adjusted earnings per share of $0.42 in the third quarter Adjusted EBITDA of $142 million in the third quarter, representing year-over-year growth of 5% $198 million in total debt reduction in the third quarter “Our third quarter results demonstrated our ability to deli...
Owens & Minor Announces Third Quarter 2024 Earnings Release Date and C...
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2024 on Monday, November 4, 2024, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Rela...
Owens & Minor Names Jonathan Leon Executive Vice President, Chief Fina...
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE: OMI), announced today that Mr. Jonathan Leon has been named Executive Vice President, Chief Financial Officer, effective immediately. Leon will maintain his corporate treasurer responsibilities while a search for his successor is underway. Mr. Leon has been with the Company since 2017, most recently serving as Interim Chief Financial Officer and Corporate Treasurer since June 2024. He will report directly to Mr. Edward Pesicka, President and Chief Executive Officer of Owens & Minor. Mr. Leon brings more than 25 years of corporate fin...
Owens & Minor to Present at the 2024 Baird Global Healthcare Conferenc...
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE: OMI), announced today that Ed Pesicka, the Company’s President and Chief Executive Officer and Jon Leon, Corporate Treasurer and interim Chief Financial Officer, will participate in a fireside chat at 1:25 p.m. Eastern Daylight Time on Tuesday, September 10, 2024 at Baird’s Global Healthcare Conference in New York City. Owens & Minor is also hosting one-on-one meetings with investors at the conference. About Owens & Minor Owens & Minor, Inc. () is a Fortune 500 global healthcare solutions company providing essential products and ser...
Owens & Minor, Inc. - June 2024 (LTM): Peer Snapshot
Compares key performance metrics against industry peers.
Owens & Minor, Inc.: Update following revision of outlook to negative
Our credit view of this issuer reflects its extensive relationships with medical product manufacturers, offset by its low margins in the distribution business and moderately high leverage.
Owens & Minor Reports Second Quarter 2024 Financial Results
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2024. Key Highlights: Consolidated revenue of $2.7 billion in the second quarter, representing year-over-year growth of 4% Net loss of $(32) million or $(0.42) per share in the second quarter Adjusted EBITDA of $127 million in the second quarter, representing year-over-year growth of 12% Doubled second quarter year over year Adjusted earnings per share from $0.18 to $0.36 “Our second-quarter performance is consistent with our expectations, as ...
Moody's Ratings revises Owens & Minor's outlook to negative; affirms B...
Moody's Ratings (Moody's) revised Owens & Minor, Inc.'s ("Owens & Minor") outlook to negative from stable. Concurrently, we affirmed Owens & Minor's existing ratings, including the company's Ba3 Corporate Family Rating (CFR), Ba3-PD Probability of Default Rating (PDR), the Ba3 rating on its senior s...
Owens & Minor, Inc. Releases Preliminary Second Quarter 2024 Financial...
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE: OMI) today announced selected preliminary financial results for the quarter ended June 30, 2024 as noted in the table below. The Company also reaffirmed its outlook for the full year 2024 as noted below in advance of its second quarter 2024 earnings announcement and conference call. Selected Preliminary Financial Results for the Quarter Ended June 30, 2024 (1) ($ in millions, except per share data) 2Q24 Revenue $2,651 - $2,671 Operating income, G...
Owens & Minor, Inc. Signs Definitive Agreement to Acquire Rotech Healt...
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (“Owens & Minor”) (NYSE: OMI), today announced that it has entered into a definitive agreement to acquire Rotech Healthcare Holdings, Inc. (“Rotech”), a privately held home based care business headquartered in Orlando, Florida, for $1.36 billion in cash. Given anticipated tax benefits of approximately $40 million from the transaction, the net purchase price is approximately $1.32 billion, which represents approximately a 6.3x multiple of LTM EBITDA, excluding synergies. Rotech is a national leader in providing home medical equipment in the...
Owens & Minor Inc: 1 director
A director at Owens & Minor Inc sold 20,015 shares at 17.487USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Owens & Minor, Inc. - March 2024 (LTM): Peer Snapshot
Compares key performance metrics against industry peers.
Owens & Minor to Present at the Leerink Partners’ Healthcare Crossroad...
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution services and innovative technology, announced today that Ed Pesicka, the Company’s President and Chief Executive Officer and Alex Bruni, the Company’s Executive Vice President and Chief Financial Officer, will participate in a webcasted fireside chat at 11:00 a.m. Eastern Daylight Time on Wednesday, May 29, 2024 at Leerink Partners’ Healthcare Crossroads Conference i...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.